Asthma: What next when your patient does not respond to therapy

Research output: Contribution to journalArticle

Abstract

A number of key steps can be taken to identify factors that may be interfering with your patient's response to asthma therapy. The most obvious initial steps are to confirm that the diagnosis of asthma is correct and that the patient has been receiving therapy based on published guidelines, which emphasize the early use of inhaled anti-inflammatory agents for all patients except those with mild, intermittent asthma. Carefully assess the degree to which the patient is adhering to the prescribed regimen. Poor understanding of the benefits of medications may lead to noncompliance with antiinflammatory therapy. Make sure that the patient is carefully taught how to use a metered-dose inhaler (MDI), and periodically assess his or her MDI technique. Also evaluate potential aggravating factors, such as allergens and other exposures, sinusitis, and gastroesophageal reflux disease.

Original languageEnglish
Pages (from-to)1853-1858
Number of pages6
JournalConsultant
Volume36
Issue number9
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Asthma
Metered Dose Inhalers
Anti-Inflammatory Agents
Therapeutics
Sinusitis
Gastroesophageal Reflux
Allergens
Guidelines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Asthma : What next when your patient does not respond to therapy. / Calhoun, William.

In: Consultant, Vol. 36, No. 9, 09.1996, p. 1853-1858.

Research output: Contribution to journalArticle

@article{0a99f36a1d8241e99c987f33425c0170,
title = "Asthma: What next when your patient does not respond to therapy",
abstract = "A number of key steps can be taken to identify factors that may be interfering with your patient's response to asthma therapy. The most obvious initial steps are to confirm that the diagnosis of asthma is correct and that the patient has been receiving therapy based on published guidelines, which emphasize the early use of inhaled anti-inflammatory agents for all patients except those with mild, intermittent asthma. Carefully assess the degree to which the patient is adhering to the prescribed regimen. Poor understanding of the benefits of medications may lead to noncompliance with antiinflammatory therapy. Make sure that the patient is carefully taught how to use a metered-dose inhaler (MDI), and periodically assess his or her MDI technique. Also evaluate potential aggravating factors, such as allergens and other exposures, sinusitis, and gastroesophageal reflux disease.",
author = "William Calhoun",
year = "1996",
month = "9",
language = "English",
volume = "36",
pages = "1853--1858",
journal = "Consultant",
issn = "0010-7069",
publisher = "Cliggott Publishing Co.",
number = "9",

}

TY - JOUR

T1 - Asthma

T2 - What next when your patient does not respond to therapy

AU - Calhoun, William

PY - 1996/9

Y1 - 1996/9

N2 - A number of key steps can be taken to identify factors that may be interfering with your patient's response to asthma therapy. The most obvious initial steps are to confirm that the diagnosis of asthma is correct and that the patient has been receiving therapy based on published guidelines, which emphasize the early use of inhaled anti-inflammatory agents for all patients except those with mild, intermittent asthma. Carefully assess the degree to which the patient is adhering to the prescribed regimen. Poor understanding of the benefits of medications may lead to noncompliance with antiinflammatory therapy. Make sure that the patient is carefully taught how to use a metered-dose inhaler (MDI), and periodically assess his or her MDI technique. Also evaluate potential aggravating factors, such as allergens and other exposures, sinusitis, and gastroesophageal reflux disease.

AB - A number of key steps can be taken to identify factors that may be interfering with your patient's response to asthma therapy. The most obvious initial steps are to confirm that the diagnosis of asthma is correct and that the patient has been receiving therapy based on published guidelines, which emphasize the early use of inhaled anti-inflammatory agents for all patients except those with mild, intermittent asthma. Carefully assess the degree to which the patient is adhering to the prescribed regimen. Poor understanding of the benefits of medications may lead to noncompliance with antiinflammatory therapy. Make sure that the patient is carefully taught how to use a metered-dose inhaler (MDI), and periodically assess his or her MDI technique. Also evaluate potential aggravating factors, such as allergens and other exposures, sinusitis, and gastroesophageal reflux disease.

UR - http://www.scopus.com/inward/record.url?scp=29744439782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29744439782&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:29744439782

VL - 36

SP - 1853

EP - 1858

JO - Consultant

JF - Consultant

SN - 0010-7069

IS - 9

ER -